Dermatology Podcast ArchivesFeatured PodcastPodcast Highlights

Don’t Fear, Getting Involved with NEA is Oh So Clear

By December 29, 2022No Comments

JDD Multimedia

JDD Podcast

Don't Fear, Getting Involved with NEA is Oh So Clear

Wendy Smith-Begolka & Adam Friedman, MD, FAAD

Cutting the cord for residency training can feel like losing one’s Netflix account, distanced from the epicenter of cultural or dermatologic life. How to stay engaged, involved, or even keep your finger on the rapid pulse of innovation or development you ask? It’s as simple as sending an email. JDD Podcast host Dr. Adam Friedman takes a deep dive with National Eczema Association (NEA) Vice President of Scientific and Clinical Affairs Wendy Smith-Begolka on all paths to engagement. Education, research, community advocacy…it’s all there and a 5 gm sample tube throw away (meaning real close). Tune in to learn how to continue the cutaneous connection.

This podcast series is supported by Pfizer.

Listen Now
HOST: Adam Friedman, MD, FAAD
GUEST: Wendy Smith-Begolka

You May Also Like

Scouting the Scalp: Practical and Case-Based Approaches to Managing Hair and Scalp Diseases

| Featured Articles, Featured Podcast, Hair, Podcast Highlights, The Latest | No Comments
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some  inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…

Treat to (Stay on) Target(ted Therapies)

| Featured Articles, Featured Podcast, Podcast Highlights, Skin Cancer, The Latest | No Comments
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…

State of the Acne Management Union: Stud or Dud?

| Acne, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Don't pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away…

Leave a Reply